Triple carcinomas detected in two patients with anti-transcription intermediary factor 1γ (TIF1γ) antibody-positive dermatomyositis

被引：0
|
作者：
Shimono, Masahiro [1 ]
Koike, Yuta [1 ]
Satomi, Naoyoshi [1 ]
Morisaki, Hitomi [1 ]
Ashida, Miwa [1 ]
Murota, Hiroyuki [1 ]
机构：
[1] Nagasaki Univ Grad, Sch Biomed Sci, Dept Dermatol, Nagasaki, Japan
来源：
EUROPEAN JOURNAL OF DERMATOLOGY | 2022年 / 32卷 / 02期
关键词：
D O I：
10.1684/ejd.2022.4232
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：285 / 287
页数：4
相关论文
共 50 条
  • [31] Microbial signatures in TIF1γ autoantibody positive dermatomyositis patients
    Megremis, S.
    Walker, T.
    He, X.
    O'Sullivan, J.
    Payton, A.
    Pendleton, N.
    Hampson, L.
    Cooper, R.
    Ollier, W.
    Chinoy, H.
    Hampson, I.
    Lamb, J.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 104 - 104
  • [32] Anti-Transcription Intermediary Factor 1-Gamma (TIF1-γ) Autoantibody ELISA Development and Validation.
    Aggarwal, Rohit
    Oddis, Chester V.
    Fertig, Noreen
    Goudeau, Danielle
    Koontz, Diane
    Stephans, Chad
    Qi, Zengbiao
    Levesque, Marc C.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S826 - S826
  • [33] Anti-transcription intermediary factor 1 γ antibody titer correlates with clinical symptoms in a patient with recurrent dermatomyositis associated with ovarian cancer
    Teraishi, Mika
    Nakajima, Kimiko
    Ishimoto, Tatsushi
    Yamamoto, Mayuko
    Maeda, Nagamasa
    Muro, Yoshinao
    Sano, Shigetoshi
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2018, 21 (04) : 900 - 902
  • [34] Analysis of human total antibody repertoires in TIF1γ autoantibody positive dermatomyositis
    Spyridon Megremis
    Thomas D. J. Walker
    Xiaotong He
    James O’Sullivan
    William E. R. Ollier
    Hector Chinoy
    Neil Pendleton
    Antony Payton
    Lynne Hampson
    Ian Hampson
    Janine A. Lamb
    Communications Biology, 4
  • [35] Analysis of human total antibody repertoires in TIF1γ autoantibody positive dermatomyositis
    Megremis, Spyridon
    Walker, Thomas D. J.
    He, Xiaotong
    O'Sullivan, James
    Ollier, William E. R.
    Chinoy, Hector
    Pendleton, Neil
    Payton, Antony
    Hampson, Lynne
    Hampson, Ian
    Lamb, Janine A.
    COMMUNICATIONS BIOLOGY, 2021, 4 (01)
  • [36] Changes in antibody titres in patients with anti transcription intermediary factor 1-gamma antibody-positive idiopathic inflammatory myositis
    Abe, Yoshiyuki
    Ando, Taiki
    Matsushita, Masakazu
    Tada, Kurisu
    Yamaji, Ken
    Tamura, Naoto
    RHEUMATOLOGY, 2019, 58 (01) : 179 - 181
  • [37] NivolumabAnti-transcriptional intermediary factor 1γ antibody-positive dermatomyositis: case report
    Reactions Weekly, 2023, 1972 (1) : 279 - 279
  • [38] Pregnancy triggers the onset of anti-transcriptional intermediary factor 1γ antibody-positive dermatomyositis: a case series
    Oya, Kazumasa
    Inoue, Sae
    Saito, Akimasa
    Nakamura, Yoshiyuki
    Ishitsuka, Yosuke
    Fujisawa, Yasuhiro
    Watanabe, Rei
    Taguchi, Shijima
    Fujimoto, Manabu
    Okiyama, Naoko
    RHEUMATOLOGY, 2020, 59 (06) : 1450 - 1451
  • [39] DurvalumabAnti-TIF1γ antibody-positive dermatomyositis: case report
    Reactions Weekly, 2021, 1876 (1) : 132 - 132
  • [40] Anti-TIF1-γ antibody-positive dermatomyositis caused by camrelizumab in a patient with oesophageal cancer
    Li, J.
    Yi, S.
    Huang, Y.
    Peng, Y.
    Yang, Z.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (02) : 395 - 395
12345